Startup profile · funding coverage
Cedar
Patient financial engagement platform simplifying medical billing for health systems.
Stage
growth
Status
private
Coverage
full
Why Cedar is interesting
Category leader in patient-centric revenue cycle — Tiger-led D round with Thrive and Founders Fund alongside a16z.
Key facts
- Series D (2021): $200M led by Tiger Global at $3.2B valuation; a16z, Thrive participated (PR Newswire)
- Series C (2020): $102M led by a16z; Thrive, Founders Fund among participants (Cedar press)
Investors in our directory
Funds linked from Cedar's profile — open a fund page for stage focus and related deal articles.
Industries
Healthtech Enterprise SaaS
Industry hub pages are rolling out from our fund-derived baseline taxonomy.
FAQs about Cedar
Funding context and why this company shows up in venture coverage.
Cedar helps hospitals and health systems present clearer medical bills, offer flexible payment options, and automate patient billing outreach — improving both collections and satisfaction.
Andreessen Horowitz (see /fund/andreessen-horowitz) led the $102M Series C in 2020. Tiger Global Management (see /fund/tiger-global-management) led the $200M Series D at $3.2B in 2021; Thrive Capital (see /fund/thrive-capital) and Founders Fund (see /fund/founders-fund) participated.
Growth stage after Series D ($200M, 2021 at $3.2B valuation). Cedar remains private.
Patient billing is a top complaint in U.S. healthcare — Cedar became a category leader in patient-centric revenue cycle, now embedded in major health-system workflows.
No — Cedar remains a private company.
Last updated: 2026-07-24